Home News Dwight and Dian Diercks’ $20M Boost to Transform AI and Innovation at...

Dwight and Dian Diercks’ $20M Boost to Transform AI and Innovation at Mayo Clinic

0
Dwight and Dian Diercks' $20M Boost to Transform AI and Innovation at Mayo Clinic

Rochester- 27 June 2024- A generous $20 million gift from Dwight and Dian Diercks will fuel key elements of Mayo Clinic’s vision for the future of healthcare, including Mayo Clinic Platform and the application of artificial intelligence (AI) for early detection and intervention in cancer. In honor of their support, Mayo Clinic will establish the Dwight and Dian Diercks President, Mayo Clinic Platform, and create the Heidi Diercks Krause Fund in AI Innovation for Cancer, named in honor of Mr. Diercks’ late sister.

“The Dierckses’ visionary investment will bolster Mayo Clinic’s efforts through the Platform to curate the world’s de-identified data, empower solution developers and transform healthcare around the world,” says John Halamka, M.D., the inaugural Dwight and Dian Diercks President, Mayo Clinic Platform.

“Through the reach of Mayo Clinic Platform, the Dierckses’ remarkable generosity will accelerate new innovations that fundamentally change how health systems and care teams provide care to improve patients’ lives,” says Dr. Halamka, who also holds the Michael D. Brennan, M.D., President’s Strategic Initiative Professorship.

Also Read: Mayo Clinic Platform expands the global footprint of its distributed data network

Moreover, The Heidi Diercks Krause Fund in AI Innovation for Cancer will enable Mayo Clinic’s Generative Artificial Intelligence Program and Mayo Clinic’s Comprehensive Cancer Center to advance answers for cancer. An example of this work includes developing advanced generative AI tools to gain deep insights into a person’s risk of developing cancer. This forecasting will allow clinicians to intervene earlier than ever before — even before cancer can be diagnosed.

“We are profoundly grateful to Mr. and Mrs. Diercks for their support, which will help us bring the promise of AI to patients at the earliest phases of their care journeys,” says Matthew Callstrom, M.D., Ph.D., Mayo Clinic’s medical director for Strategy, chair of Radiology in Rochester and leader of the Generative Artificial Intelligence Program. “Cancer affects people from all walks of life, and leveraging AI to tackle and treat this devastating disease will be critical for improving outcomes for all patients.”

Also Read: Eau Claire, Mankato named among America’s Best Hospitals by Healthgrades

“We can’t afford to wait years or decades for new AI breakthroughs in healthcare. People need new therapies and cures now,” says Mr. Diercks. “Dian and I truly believe that Mayo Clinic Platform and AI innovation will be the keys to better predicting diseases like cancer, so physicians can intervene sooner with more effective treatments that save, extend or improve the quality of patient lives. It gives me comfort knowing my sister’s legacy will live on through these efforts to transform cancer care for everyone. Heidi lived for her family, and having additional time with her husband, Scott, and daughter, Kate, meant the world to her. In the future, we hope that extension of time can be amplified tenfold for others.”

Exit mobile version